Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Clinical Genetics|October 23, 2009
Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1A M Nyström, S Ekvall, J Allanson, et al.
Plastic and Reconstructive Surgery|February 15, 2001
Self-reported symptoms among women after cosmetic breast implant and breast reduction surgeryJ P Fryzek, L B Signorello, L Hakelius, et al.
The British Journal of Surgery|February 12, 2011
Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancerA E Isern, J Manjer, J Malina, et al.
The British Journal of Surgery|July 13, 2018
Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flapA Svee, M Mani, K Sandquist, et al.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer GroupP Boiesen, P O Bendahl, L Anagnostaki, et al.
Genomics|July 15, 1997
Two distinct deletions in the IDS gene and the gene W: a novel type of mutation associated with the Hunter syndromeS L Karsten, K Lagerstedt, B M Carlberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2000
Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breastA Ringberg, I Idvall, M Fernö, et al.
International Journal of Cancer|January 27, 1997
Karyotypic abnormalities in fibroadenomas of the breastC Petersson, N Pandis, H Rizou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
Pageof 14